These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34633107)

  • 1. Reply to Letter to the Editor Regarding "Durability and Delayed Treatment Effects of Zoledronic Acid on Bone Loss After Spinal Cord Injury: A Randomized, Controlled Trial".
    Edwards WB; Haider IT; Simonian N; Barroso J; Schnitzer TJ
    J Bone Miner Res; 2022 Jan; 37(1):169-170. PubMed ID: 34633107
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor Regarding "Durability and Delayed Treatment Effects of Zoledronic Acid on Bone Loss After Spinal Cord Injury: A Randomized, Controlled Trial".
    Singhania P; Bhattacharjee R
    J Bone Miner Res; 2022 Jan; 37(1):167-168. PubMed ID: 34542188
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial.
    Goenka S; Sethi S; Pandey N; Joshi M; Jindal R
    Spinal Cord; 2018 Dec; 56(12):1207-1211. PubMed ID: 30258212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study.
    Bauman WA; Cirnigliaro CM; La Fountaine MF; Martinez L; Kirshblum SC; Spungen AM
    J Bone Miner Metab; 2015 Jul; 33(4):410-21. PubMed ID: 25158630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
    Shapiro J; Smith B; Beck T; Ballard P; Dapthary M; BrintzenhofeSzoc K; Caminis J
    Calcif Tissue Int; 2007 May; 80(5):316-22. PubMed ID: 17417700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.
    Bubbear JS; Gall A; Middleton FR; Ferguson-Pell M; Swaminathan R; Keen RW
    Osteoporos Int; 2011 Jan; 22(1):271-9. PubMed ID: 20358358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study.
    Oleson CV; Marino RJ; Formal CS; Modlesky CM; Leiby BE
    Spinal Cord; 2020 Aug; 58(8):921-929. PubMed ID: 32055041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic Acid Treatment After Acute Spinal Cord Injury: Results of a Randomized, Placebo-Controlled Pilot Trial.
    Schnitzer TJ; Kim K; Marks J; Yeasted R; Simonian N; Chen D
    PM R; 2016 Sep; 8(9):833-43. PubMed ID: 26828618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correspondence: "Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial".
    Beaupre GS
    Spinal Cord; 2018 Dec; 56(12):1212. PubMed ID: 30467328
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological approaches for bone health in persons with spinal cord injury.
    Bauman WA
    Curr Opin Pharmacol; 2021 Oct; 60():346-359. PubMed ID: 34534754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional electrical stimulation (FES)-assisted rowing combined with zoledronic acid, but not alone, preserves distal femur strength and stiffness in people with chronic spinal cord injury.
    Fang Y; Morse LR; Nguyen N; Battaglino RA; Goldstein RF; Troy KL
    Osteoporos Int; 2021 Mar; 32(3):549-558. PubMed ID: 32888047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid improves bone mineral density in pediatric spinal cord injury.
    Ooi HL; Briody J; McQuade M; Munns CF
    J Bone Miner Res; 2012 Jul; 27(7):1536-40. PubMed ID: 22437628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial stability of uncemented femoral stems: A randomized placebo-controlled trial of women undergoing total hip arthroplasty.
    Aro E; Moritz N; Mattila K; Aro HT
    J Biomech; 2018 Jun; 75():35-45. PubMed ID: 29747966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).
    Smith MR; Halabi S; Ryan CJ; Hussain A; Vogelzang N; Stadler W; Hauke RJ; Monk JP; Saylor P; Bhoopalam N; Saad F; Sanford B; Kelly WK; Morris M; Small EJ
    J Clin Oncol; 2014 Apr; 32(11):1143-50. PubMed ID: 24590644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.
    Santa-Maria CA; Bardia A; Blackford AL; Snyder C; Connolly RM; Fetting JH; Hayes DF; Jeter SC; Miller RS; Nguyen A; Quinlan K; Rosner GL; Slater S; Storniolo AM; Wolff AC; Zorzi J; Henry NL; Stearns V
    Breast Cancer Res Treat; 2018 Aug; 171(1):121-129. PubMed ID: 29752687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Acute Kidney Injury After Single-Dose Injection of Zoledronic Acid in an Elderly Patient.
    Im H; Choi HM; Oh DJ; Kwon YE
    Am J Ther; 2018; 25(2):e289-e290. PubMed ID: 29505491
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate cancer.
    Saad F
    Clin Prostate Cancer; 2005 Jun; 4(1):31-7. PubMed ID: 15992459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.
    Polyzos SA
    Clin Rheumatol; 2011 Jan; 30(1):149-50. PubMed ID: 21053036
    [No Abstract]   [Full Text] [Related]  

  • 19. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.
    Crawford BA; Kam C; Pavlovic J; Byth K; Handelsman DJ; Angus PW; McCaughan GW
    Ann Intern Med; 2006 Feb; 144(4):239-48. PubMed ID: 16490909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid: a new parenteral bisphosphonate.
    Li EC; Davis LE
    Clin Ther; 2003 Nov; 25(11):2669-708. PubMed ID: 14693298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.